Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [Cut&Run]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 56 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- OsteosarcomaThis series is part of our curated briefing on it.
- Samples
- 56 samples: 22 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI.
Read the full summary ↓
Direct links to NCBI, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need.
Whole study · RAW.tar
Everything the authors deposited as one archive (GSE270503_RAW.tar), including the raw array or instrument files. Can be large; the picker in step 2 takes just the samples you need.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1126764. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 56 samples.
How we read this: 22 replicated groups read from 56 sample titles; they account for 56 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8345480 OS052_IgG_1 OS052_IgG
- GSM8345481 OS052_IgG_2 OS052_IgG
- GSM8345482 OS052_H3K27Ac_1 OS052_H3K27Ac
- GSM8345483 OS052_H3K27Ac_2 OS052_H3K27Ac
- GSM8345484 OS152_IgG_1 OS152_IgG
- GSM8345485 OS152_IgG_2 OS152_IgG
- GSM8345486 OS152_IgG_3 OS152_IgG
- GSM8345487 OS152_H3K27Ac_1 OS152_H3K27Ac
- GSM8345488 OS152_H3K27Ac_2 OS152_H3K27Ac
- GSM8345489 OS152_H3K27Ac_3 OS152_H3K27Ac
- GSM8345490 OS186_IgG_1 OS186_IgG
- GSM8345491 OS186_IgG_2 OS186_IgG
- GSM8345492 OS186_H3K27Ac_1 OS186_H3K27Ac
- GSM8345493 OS186_H3K27Ac_2 OS186_H3K27Ac
- GSM8345494 OS384_IgG_1 OS384_IgG
- GSM8345495 OS384_IgG_2 OS384_IgG
- GSM8345496 OS384_H3K27Ac_1 OS384_H3K27Ac
- GSM8345497 OS384_H3K27Ac_2 OS384_H3K27Ac
- GSM8345498 OS457_IgG_1 OS457_IgG
- GSM8345499 OS457_IgG_2 OS457_IgG
- GSM8345500 OS457_H3K27Ac_1 OS457_H3K27Ac
- GSM8345501 OS457_H3K27Ac_2 OS457_H3K27Ac
- GSM8345502 OS525_IgG_1 OS525_IgG
- GSM8345503 OS525_IgG_2 OS525_IgG
- GSM8345504 OS525_H3K27Ac_1 OS525_H3K27Ac
- GSM8345505 OS525_H3K27Ac_2 OS525_H3K27Ac
- GSM8345506 OS526_IgG_1 OS526_IgG
- GSM8345507 OS526_IgG_2 OS526_IgG
- GSM8345508 OS526_IgG_3 OS526_IgG
- GSM8345509 OS526_H3K27Ac_1 OS526_H3K27Ac
- GSM8345510 OS526_H3K27Ac_2 OS526_H3K27Ac
- GSM8345511 OS526_H3K27Ac_3 OS526_H3K27Ac
- GSM8345512 OS742_IgG_1 OS742_IgG
- GSM8345513 OS742_IgG_2 OS742_IgG
- GSM8345514 OS742_IgG_3 OS742_IgG
- GSM8345515 OS742_IgG_4 OS742_IgG
- GSM8345516 OS742_IgG_5 OS742_IgG
- GSM8345517 OS742_H3K27Ac_1 OS742_H3K27Ac
- GSM8345518 OS742_H3K27Ac_2 OS742_H3K27Ac
- GSM8345519 OS742_H3K27Ac_3 OS742_H3K27Ac
+ 16 more — browse all 56 samples with per-sample file links →
- GSE270506 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma. 279 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs, drug
- GSE270502 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [ATAC-seq] 87 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs, drug
- GSE309031 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [CUT&Run] 85 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs, drug
- GSE270505 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [RNA-seq] 19 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs, drug
- GSE308957 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma. [ATAC-Seq, cell line] 18 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs, drug
- GSE270504 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [snRNAseq + snATACseq] 4 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs, drug
- GSE307240 Epigenetic and transcriptional heterogeneity define osteosarcoma subtypes and establish targetable vulnerabilities [multiomics] 10 samples same disease briefing · shares heterogeneity, osteosarcoma, epigenetic
- GSE218036 Transcriptome analysis of osteosarcoma cell lines treated with FDA-approved drugs 18 samples same disease briefing · shares osteosarcoma, drug
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.